Artwork for Sacituzumab Govitecan (Trodelvy) in Metastatic Triple-Negative Breast Cancer
Clinical Summaries presented by InpharmDâ„¢

Sacituzumab Govitecan (Trodelvy) in Metastatic Triple-Negative Breast Cancer
00:00:00 / 00:08:13